Medical Grade Carboxymethyl Cellulose Market Size, Share, Growth, and Industry Analysis, By Type (Purity (99.5 %+), Purity (90%-99.5%) and Purity (50%-90%)), By Application (Pharmaceutical, Cosmetics and Other) and Regional Forecast to 2032

Updated On: 02 September 2024

• 

  Request a Free Sample to learn more about this report

MEDICAL GRADE CARBOXYMETHYL CELLULOSE MARKET REPORT OVERVIEW

The global Medical Grade Carboxymethyl Cellulose Market size was USD 12.06 million in 2024 and the market is projected to touch USD 27.32 million by 2032, exhibiting a CAGR of 8.52% during the forecast period.

Carboxymethylcellulose is an ether carboxylic acid formed from an etherification process of cellulose with carboxymethyl chloride. It is also one of the most commonly used GPCs for artificial tears and seems to be effective in the management of ATD dry eye manifestations and OSS.

COVID-19 Impact: Market Growth increased by the Pandemic due to Increased Demand in Medical and Pharmaceutical Applications

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

The necessity for medical requirement has been impacted more during Covid-19 where each formulation that is incorporated into formation of medicines, the substrate employed in formulation and the various medical gadgets and products including the wound care and the reparative are in the list. Hence, their production saw the demand of CMC being given a boost as it is a raw material in most of these products.

LATEST TRENDS

"Increased Demand in Pharmaceuticals and Biotechnology Industry to Propel Market Growth"

This is as affirmed above that a new and high growth segment particularly of the medical grade CMC is pharmaceuticals and biotechnology. They are characterized by the extent of CMC adoption that has just acted as an international excipient in the traditional and sophisticated material and immaterial physio pharmaceutical and biopharmaceutical sectors. In the pharmaceutical usage specifically in drug tablet and capsule preparation, CMC is appreciated for characteristics it has to function with in terms of a binder, a disintegrant as well as a stabilizer in the cases where used; it gives an immediate control on the rate of drug release leading to the factor that defines bioavailability. It emphasized that the usage of CMC in the modern controlled release preparation has been highlighted because this technology affects the release rate on an active substance, a therapeutic effect, and patients’ acceptability.

• 

  Request a Free Sample to learn more about this report

MEDICAL GRADE CARBOXYMETHYL CELLULOSE MARKET SEGMENTATION

By Type

Based on type the market can be categorized into Purity (99.5 %+), Purity (90%-99.5%) and Purity (50%-90%).

Purity (99.5 %+)- This is the highest purity grade of medical grade CMC, containing 99. 5% or more pure carboxymethyl cellulose.

Purity (90%-99.5%)- This grade ranges from 90 percent and 99 percent. 5% of carboxymethyl cellulose, that combines a couple of high purity with reasonable cost.

Purity (50%-90%)- This grade is between 50% and 90% pure carboxymethyl cellulose, and is generally found in applications where purity level is not quite as important.

By Application

Based on application the market can be categorized into Pharmaceutical, Cosmetics and Other.

Pharmaceutical- Controlled Release Formulations is an extensively used concept in controlled release drug preparations. In the controlled release coatings it helps in regulating the process of releasing the active pharmaceutical ingredient so that drug may be released over the wanted rate and time that is necessary for therapeutic effect.

Cosmetics- The usage of CMC is allowed for the thickening, stabilization and also for emulsifying in the skincare preparations. It embellishes the characteristics of creams, lotions, gels; has a good feel on skin when rubbed.

DRIVING FACTORS

"Increasing Demand in Pharmaceuticals and Biotechnology to Drive Market Advancement"

One of the key driving factors in the Medical Grade Carboxymethyl Cellulose Market growth is the Increasing Demand in Pharmaceuticals and Biotechnology. The rising use of medical grade products in the pharmaceutical and biotechnology industries is perhaps the biggest stimulus for the market. Specifically, in the topical pharmaceutical organization, the requirement for enhanced drug delivery systems as well as the launch of controlled release formulations has really placed CMC into focus. It currently remains one of the most useful and important coating agents that modify the drug release rates hence improving on the drug formulation output and patient’s compliance. Further, expansion of products portfolio especially biopharmaceuticals that includes protein and peptide drugs also enhance the requirement of CMC owing to its capability to prolong the shelf life and retain the efficiency of these biologics.

"Growth in the Cosmetics Industry to Expand the Market"

The rise in the cosmetics industry plays a decisive role that boosts the medical grade CMC market because of the functional advantages and versatility of CMC in most cosmetic formulations. Thus, it remains crucial to satisfy the customers’ needs for safe and highly effective ingredients to supply growing demand in skin, hair, and body care products. CMC is employed in these products foremost as a thickening, stabilizing, as well as emulsifying agent, with the medical grade versions being specifically sought after. Convenient for creating smooth and uniform textures and consistent in creams, lotions, and gels, thus the user experience is impacted positively.

RESTRAINING FACTOR

"High Costs and Technical Challenges Poses Potential Impediments to Market Growth "

Fees or costs, as well as technology barriers, act as a strong limitations for the medical grade CMC market. Medical grade CMC requires both relatively pure reagents and sensitive preparation techniques because of the high-quality and safety requirements for the medical and pharmaceutical industries. Such processes are not only costly but also require a lot of resources; hence likely to increase production cost.

• 

  Request a Free Sample to learn more about this report

MEDICAL GRADE CARBOXYMETHYL CELLULOSE MARKET REGIONAL INSIGHTS

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.

"North America to Dominate the Market due to presence of Huge Market"

North America has emerged as the most dominant region in the Medical Grade Carboxymethyl Cellulose Market share due to a convergence of factors that propel its leadership in this dynamic industry.The health care sector has considerably developed in North American particularly US and Canada. This factor involves the promotion of well-equipped health centers, research institutes, and hospitals that create demand for high-quality medical materials such as CMC.

KEY INDUSTRY PLAYERS

"Key Players Transforming the Medical Grade Carboxymethyl Cellulose Landscape through Innovation and Global Strategy"

Major industry players are pivotal in shaping the Medical Grade Carboxymethyl Cellulose Market, driving change through a dual strategy of continuous innovation and a well-thought-out global presence. By consistently introducing inventive solutions and staying at the forefront of technological progress, these key players redefine the industry's standards. Simultaneously, their expansive global reach enables effective market penetration, addressing diverse needs across borders. The seamless blend of groundbreaking innovation and a strategic international footprint positions these players as not only market leaders but also as architects of transformative shifts within the dynamic domain of Medical Grade Carboxymethyl Cellulose.

List of Market Players Profiled

• Daicel(Japan)
• DKS (Japan)
• Akzo Nobel (Netherlands)
• Ugur Seluloz Kimya AS (Turkey)
• Ashland(S.)

INDUSTRIAL DEVELOPMENT

June 2023: New Polyplasdone TM Plus multifunctional disintegrant was launched by Ashland for improving the drug production volume in the pharmaceutical industry.

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.